The clinical outcome of eribulin treatment in Japanese patients with advanced soft tissue sarcoma: a Tokai Musculoskeletal Oncology Consortium study-Reference-Cited by-同舟云学术

The clinical outcome of eribulin treatment in Japanese patients with advanced soft tissue sarcoma: a Tokai Musculoskeletal Oncology Consortium study

Published:2019-06-17 Issue:4 Volume:36 Page:343-350
ISSN:0262-0898
Container-title:Clinical & Experimental Metastasis
language:en
Short-container-title:Clin Exp Metastasis

Author:

Nakamura Tomoki^ORCID,Tsukushi Satoshi,Asanuma Kunihiro,Katagiri Hirohisa,Ikuta Kunihiro,Nagano Akihito,Kozawa Eiji,Yamada Satoshi,Shido Yoji,Yamada Kenji,Kawanami Katsuhisa,Ishimura Daisuke,Sudo Akihiro,Nishida Yoshihiro

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s10585-019-09980-3.pdf

Reference18 articles.

1. Clark MA, Fisher C, Judson I et al (2005) Soft-tissue sarcomas in adults. N Engl J Med 353:701–711

2. Zager GK, Ballo MT, Pesters PW et al (2003) Prognostic factors for patients with localized soft-tissue sarcoma treated with conservation surgery and radiation therapy; an analysis of 1225 patients. Cancer 97:2530–2543

3. Weiss SW, Goldblum JR (2001) Local recurrence. Enzinger and Weiss’s soft tissue tumors, 4th edn. Mosby, St. Louis, pp 28–32

4. Kane JM, Finley JW, Driscoll D et al (2002) The treatment and outcome of patients with soft tissue sarcomas and synchronous metastases. Sarcoma 6:69–73

5. Pollock RE, Karnell LH, Menck HR et al (1996) The national cancer data base report on soft tissue sarcoma. Cancer 87:2247–2257

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A study protocol for an open‐label, single‐arm, single‐center phase I clinical study on tolerability, safety, and efficacy of dalpiciclib combined with apatinib in the treatment of patients with advanced or metastatic sarcoma;Thoracic Cancer;2024-01-11

2. Biology and Management of High-Grade Myxofibrosarcoma: State of the Art and Future Perspectives;Diagnostics;2023-09-22

3. Current research and management of undifferentiated pleomorphic sarcoma/myofibrosarcoma;Frontiers in Genetics;2023-02-16

4. The Characteristics of magnetic resonance imaging and immunohistochemical findings in de-differentiated liposarcoma;Journal of Orthopaedic Surgery;2023-01

5. Safety and effectiveness of eribulin in Japanese patients with soft tissue sarcoma including rare subtypes: a post-marketing observational study;BMC Cancer;2022-05-11